Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127060652 | 12706065 | 2 | F | 20160426 | 20160901 | 20160901 | PER | US-JAZZ-2016-US-007850 | JAZZ | 0.00 | M | Y | 0.00000 | 20160901 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127060652 | 12706065 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | U | 21196 | 4.5 | G | ORAL SOLUTION | ||||||
| 127060652 | 12706065 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.5 G, BID | U | 21196 | 2.5 | G | ORAL SOLUTION | ||||||
| 127060652 | 12706065 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | U | 21196 | ORAL SOLUTION | ||||||||
| 127060652 | 12706065 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | U | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 127060652 | 12706065 | 5 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127060652 | 12706065 | 6 | C | ASPIRIN. | ASPIRIN | 1 | U | 0 | |||||||||||
| 127060652 | 12706065 | 7 | C | CIALIS | TADALAFIL | 1 | U | 0 | |||||||||||
| 127060652 | 12706065 | 8 | C | COENZYME Q10 | UBIDECARENONE | 1 | U | 0 | |||||||||||
| 127060652 | 12706065 | 9 | C | Fish oil concentrate | 2 | U | 0 | ||||||||||||
| 127060652 | 12706065 | 10 | C | MULTIVITAMIN WITH FLUORIDE NOS | SODIUM FLUORIDEVITAMINS | 1 | U | 0 | |||||||||||
| 127060652 | 12706065 | 11 | C | PROPECIA | FINASTERIDE | 1 | U | 0 | |||||||||||
| 127060652 | 12706065 | 12 | C | Melatonin | MELATONIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127060652 | 12706065 | 1 | Narcolepsy |
| 127060652 | 12706065 | 5 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127060652 | 12706065 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127060652 | 12706065 | 1 | 201005 | 2010 | 0 | |
| 127060652 | 12706065 | 2 | 201109 | 201110 | 0 | |
| 127060652 | 12706065 | 4 | 201502 | 0 |